Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 2Other neoplasm 1

Conditions

Malignant Neoplasms of Independent (Primary) Multiple Sites 1Gastrointestinal Neoplasms 1Gastrointestinal Malignancy 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Electrocardiography, Ambulatory × Clear all
NCT07456852 2026-06-02

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Mayo Clinic

Phase 1/2 Recruiting
60 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT06538610 2024-12-09

The 5-FU Holter Study

University of Auckland, New Zealand

Phase NA Recruiting
10 enrolled
Gastrointestinal

Gastrointestinal Malignancy

NCT03177681 2023-03-27

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

M.D. Anderson Cancer Center

Phase NA Withdrawn
Other neoplasm

Malignant Neoplasms of Independent (Primary) Multiple Sites

Data powered by HemOnc (CC BY 4.0) Colophon âš¡